Showing results (1-10 of 684) with videos related to
Sort By:
Pageof 69
Biological Chemistry Hoppe-Seyler|January 1, 1996
Minimally modified oligonucleotides - combination of end-capping and pyrimidine-protectionA Peyman, E UhlmannAntisense & Nucleic Acid Drug Development|August 1, 1997
Studies on the mechanism of stabilization of partially phosphorothioated oligonucleotides against nucleolytic degradationE Uhlmann, A Ryte, A PeymanBiological Chemistry Hoppe-Seyler|March 1, 1995
Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1A Peyman, M Helsberg, G Kretzschmar, et al.Anti-Cancer Drugs|June 1, 2000
Inhibition of Ras p21 synthesis by antisense undecamers with uniform and specifically arranged phosphorothioate linkagesA Rait, E Uhlmann, A Peyman, et al.Antiviral Research|January 1, 1997
Nuclease stability as dominant factor in the antiviral activity of oligonucleotides directed against HSV-1 IE110A Peyman, M Helsberg, G Kretzschmar, et al.The European Journal of Neuroscience|May 1, 1994
Inhibition of c-Fos protein expression in rat spinal cord by antisense oligodeoxynucleotide superfusionF Gillardon, H Beck, E Uhlmann, et al.Bioorganic & Medicinal Chemistry|February 12, 1998
Synthesis and binding properties of oligodeoxynucleotides containing phenylphosphon(othio)ate linkagesM Mag, J Muth, K Jahn, et al.Nature|October 10, 1996
c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorptionS Tanaka, M Amling, L Neff, et al.Bioconjugate Chemistry|March 22, 2000
3'-End conjugates of minimally phosphorothioate-protected oligonucleotides with 1-O-hexadecylglycerol: synthesis and anti-ras activity in radiation-resistant cellsA Rait, K Pirollo, D W Will, et al.Current Opinion in Drug Discovery & Development|August 4, 2009
Recent advances in the medicinal chemistry of antisense oligonucleotidesE UhlmannPageof 69